Severe malaria and artesunate treatment, Norway

Emerging Infectious Diseases

Volumn 14, Issue 11, 2008, Pages 1816-1818

  Mørch, Kristine ^a   Strand, Øystein ^b   Dunlop, Oona ^c   Berg, Åse ^d   Langeland, Nina ^a   Leiva, Rafael A M ^a   Longva, Jørn Åge ^a,e   Sjursen, Håkon ^a   Skrede, Steinar ^a   Sundal, Jon ^d   Jensenius, Mogens ^c  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d STAVANGER UNIVERSITY HOSPITAL   (Norway)

^e Aalesund Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CLINDAMYCIN; DOXYCYCLINE; MEFLOQUINE; QUININE;

ABSENCE OF SIDE EFFECTS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EXCHANGE BLOOD TRANSFUSION; GOOD MANUFACTURING PRACTICE; HUMAN; LETTER; LOADING DRUG DOSE; MALARIA FALCIPARUM; MEDICAL SOCIETY; MONOTHERAPY; NORWAY; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 55549122673     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1411.080636     Document Type: Letter

References (10)

1. Jelinek T, Schulte C, Behrens R, Grobusch MP, Coulaud JR, Bisoffi Z, et al. Imported falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis. 2002;34:572-6. DOI: 10.1086/338235
2. Bottieau E, Clerinx J, Schrooten W, Van den Enden E, Wouters R, Van Esbroeck M, et al. Etiology and outcome of fever after a stay in the tropics. Arch Intern Med. 2006;166:1642-8. DOI: 10.1001/archinte.166.15.1642
3. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg. 2000;94(Suppl 1):1-90.
4. Woodrow CJ, Haynes RK, Krishna S. Artemisinins. Postgrad Med J. 2005;81:71-8. DOI: 10.1136/pgmj.2004.028399
5. Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. N Engl J Med. 2008;358:1829-36. DOI: 10.1056/NEJMct0709050
6. Wongsrichanalai C, Meshnick SR. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border. Emerg Infect Dis. 2008;14:716-9.
7. Jones KL, Donegan S, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst Rev. 2007;(4):CD005967.
8. World Health Organization. Guidelines for the treatment of malaria. 2006 [cited 2008 Sep 11]. Available from http://www.who.int/malaria/docs/ TreatmentGuidelines2006.pdf
9. Jelinek T. Intravenous artesunate recommended for patients with severe malaria: position statement from TropNetEurop. Euro Surveill, 2005;10(11): p. E051124 5.
10. Lalloo DG, Somgadoa D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, et al. UK malaria treatment guidelines. J Infect. 2007;54:111-21. DOI: 10.1016/j.jinf.2006.12.003